Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-17
DOI
10.3389/fimmu.2019.02989
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice
- (2019) Graham J. Britton et al. IMMUNITY
- A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
- (2019) Takeshi Tanoue et al. NATURE
- The diversity of gut microbiome is associated with favorable responses to anti-PD-1 immunotherapy in Chinese non-small cell lung cancer patients
- (2019) Yueping Jin et al. Journal of Thoracic Oncology
- Mid-life microbiota crises: middle age is associated with pervasive neuroimmune alterations that are reversed by targeting the gut microbiome
- (2019) Marcus Boehme et al. MOLECULAR PSYCHIATRY
- T cell–mediated regulation of the microbiota protects against obesity
- (2019) Charisse Petersen et al. SCIENCE
- The gut microbiota influences skeletal muscle mass and function in mice
- (2019) Shawon Lahiri et al. Science Translational Medicine
- Microbiota-Driven Tonic Interferon Signals in Lung Stromal Cells Protect from Influenza Virus Infection
- (2019) Konrad C. Bradley et al. Cell Reports
- Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
- (2019) Yi Zheng et al. Journal for ImmunoTherapy of Cancer
- Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
- (2019) Erick Riquelme et al. CELL
- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
- (2018) L Derosa et al. ANNALS OF ONCOLOGY
- IgA Function in Relation to the Intestinal Microbiota
- (2018) Andrew J. Macpherson et al. Annual Review of Immunology
- Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response
- (2018) Vrishketan Sethi et al. GASTROENTEROLOGY
- Gut microbiota modulate T cell trafficking into human colorectal cancer
- (2018) Eleonora Cremonesi et al. GUT
- Gut microbiome modulates efficacy of immune checkpoint inhibitors
- (2018) Ming Yi et al. Journal of Hematology & Oncology
- Gut microbiota utilize immunoglobulin A for mucosal colonization
- (2018) G. P. Donaldson et al. SCIENCE
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
- (2018) Smruti Pushalkar et al. Cancer Discovery
- Modulation of Inflammatory Arthritis in Mice by Gut Microbiota Through Mucosal Inflammation and Autoantibody Generation
- (2018) Widian K. Jubair et al. Arthritis & Rheumatology
- Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
- (2018) Yinghong Wang et al. NATURE MEDICINE
- Adoptive cell therapy: past, present and future
- (2017) Jonathan E Cohen et al. Immunotherapy
- Bifidobacteriumcan mitigate intestinal immunopathology in the context of CTLA-4 blockade
- (2017) Feng Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Probiotic species in the modulation of the anticancer immune response
- (2017) Luciana Marinelli et al. SEMINARS IN CANCER BIOLOGY
- Erratum: Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
- (2017) Shu Su et al. Scientific Reports
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
- (2017) Arthur E. Frankel et al. NEOPLASIA
- The path towards microbiome-based metabolite treatment
- (2017) Jotham Suez et al. Nature Microbiology
- Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells
- (2016) Toshiko Kamata et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- The untold story of IFN-γ in cancer biology
- (2016) M. Alper Kursunel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
- (2016) Frank A. Schildberg et al. IMMUNITY
- Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
- (2016) Romain Daillère et al. IMMUNITY
- Emerging Concepts on the Gut Microbiome and Multiple Sclerosis
- (2016) Justin D. Glenn et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Linking the Microbiota, Chronic Disease, and the Immune System
- (2016) Timothy W. Hand et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
- (2016) Krista Dubin et al. Nature Communications
- Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
- (2016) Lewis Zhichang Shi et al. Nature Communications
- The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
- (2016) Kankana Bardhan et al. Frontiers in Immunology
- Microbiota-Mediated Inflammation and Antimicrobial Defense in the Intestine
- (2015) Silvia Caballero et al. Annual Review of Immunology
- Treatment of Recurrent and SevereClostridium DifficileInfection
- (2015) J.J. Keller et al. Annual Review of Medicine
- Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy
- (2015) Xiangjiao Meng et al. CANCER TREATMENT REVIEWS
- Gut Microbiota Orchestrates Energy Homeostasis during Cold
- (2015) Claire Chevalier et al. CELL
- Microbiota in Allergy and Asthma and the Emerging Relationship with the Gut Microbiome
- (2015) Kei E. Fujimura et al. Cell Host & Microbe
- Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
- (2015) Fredrik Bäckhed et al. Cell Host & Microbe
- Manipulating IL-10 signalling blockade for better immunotherapy
- (2015) Guoying Ni et al. CELLULAR IMMUNOLOGY
- CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity
- (2015) Isabel Vogel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Adoptive T-cell therapy for cancer: The era of engineered T cells
- (2015) Chiara Bonini et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunological Effects of a Tumor Necrosis Factor Alpha–Armed Oncolytic Adenovirus
- (2015) Mari Hirvinen et al. HUMAN GENE THERAPY
- Programmed death-1 & its ligands: promising targets for cancer immunotherapy
- (2015) Rajeev K Shrimali et al. Immunotherapy
- Immune Checkpoint inhibitors: An introduction to the next-generation cancer immunotherapy
- (2015) Lucy Lee et al. JOURNAL OF CLINICAL PHARMACOLOGY
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Role of the Gut Microbiome in Obesity and Diabetes Mellitus
- (2015) Gillian M. Barlow et al. NUTRITION IN CLINICAL PRACTICE
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Cancer and the gut microbiota: An unexpected link
- (2015) Laurence Zitvogel et al. Science Translational Medicine
- Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
- (2015) Kim C. Ohaegbulam et al. TRENDS IN MOLECULAR MEDICINE
- CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations
- (2015) Luis H. Camacho Cancer Medicine
- Harnessing the Microbiome to Enhance Cancer Immunotherapy
- (2015) Michelle H. Nelson et al. Journal of Immunology Research
- PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity
- (2015) Tong Seng Lim et al. OncoImmunology
- The effect of short-chain fatty acids on human monocyte-derived dendritic cells
- (2015) Claudia Nastasi et al. Scientific Reports
- Large B-Cell Lymphomas Poor in B Cells and Rich in PD-1+ T Cells Can Mimic T-Cell Lymphomas
- (2014) Robert S. Ohgami et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human Genetics Shape the Gut Microbiome
- (2014) Julia K. Goodrich et al. CELL
- Gut microbiome and anticancer immune response: really hot Sh*t!
- (2014) S Viaud et al. CELL DEATH AND DIFFERENTIATION
- Gut Dysbiosis Promotes M2 Macrophage Polarization and Allergic Airway Inflammation via Fungi-Induced PGE2
- (2014) Yun-Gi Kim et al. Cell Host & Microbe
- PD-1 regulates extrathymic regulatory T-cell differentiation
- (2014) Xiufen Chen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies
- (2014) Fergus Shanahan et al. GASTROENTEROLOGY
- Does the microbiota play a role in the pathogenesis of autoimmune diseases?
- (2014) Mairi H McLean et al. GUT
- Microbiota and diabetes: an evolving relationship
- (2014) Herbert Tilg et al. GUT
- Therapeutic use of anti-CTLA-4 antibodies
- (2014) C. U. Blank et al. INTERNATIONAL IMMUNOLOGY
- Diet, microbiota and autoimmune diseases
- (2014) SM Vieira et al. LUPUS
- Acquired and intrinsic resistance in cancer immunotherapy
- (2014) Sander Kelderman et al. Molecular Oncology
- Fecal microbiota transplantation: effectiveness, complexities and lingering concerns
- (2014) E G Pamer Mucosal Immunology
- Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
- (2014) Aurélien Trompette et al. NATURE MEDICINE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
- (2014) Pamela V. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome
- (2013) Yehuda Ringel et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Dendritic cell immunotherapy
- (2013) Rachel Lubong Sabado et al. Annals of the New York Academy of Sciences
- Replenishing our defensive microbes
- (2013) Luke K. Ursell et al. BIOESSAYS
- Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses
- (2013) G. Nizzoli et al. BLOOD
- Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
- (2013) Nicholas Arpaia et al. NATURE
- A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
- (2013) Taku Okazaki et al. NATURE IMMUNOLOGY
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis
- (2013) P. M. Smith et al. SCIENCE
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- A metagenomic insight into our gut's microbiome
- (2012) Patricia Lepage et al. GUT
- Cancer immunoediting by the innate immune system in the absence of adaptive immunity
- (2012) Timothy O’Sullivan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genomic approaches to studying the human microbiota
- (2012) George M. Weinstock NATURE
- Gut-central nervous system axis is a target for nutritional therapies
- (2012) Gustavo D Pimentel et al. Nutrition Journal
- Host-Gut Microbiota Metabolic Interactions
- (2012) J. K. Nicholson et al. SCIENCE
- Cetuximab therapy in head and neck cancer: Immune modulation with interleukin-12 and other natural killer cell–activating cytokines
- (2012) Eric Luedke et al. SURGERY
- Dual biological effects of the cytokines interleukin-10 and interferon-γ
- (2011) Cailin Moira Wilke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti-CTLA-4 Therapy
- (2011) T. Fu et al. CANCER RESEARCH
- Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
- (2011) E. J. Lipson et al. CLINICAL CANCER RESEARCH
- Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer
- (2011) James J Farrell et al. GUT
- intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface
- (2011) A. S. Ismail et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Antibacterial Lectin RegIII Promotes the Spatial Segregation of Microbiota and Host in the Intestine
- (2011) S. Vaishnava et al. SCIENCE
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- CTLA-4 is expressed by human monocyte—derived dendritic cells and regulates their functions
- (2010) Stefania Laurent et al. HUMAN IMMUNOLOGY
- Gut Microbiota in Health and Disease
- (2010) Inna Sekirov et al. PHYSIOLOGICAL REVIEWS
- Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota
- (2010) J. L. Round et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Succession of microbial consortia in the developing infant gut microbiome
- (2010) J. E. Koenig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune Responses
- (2010) S. Hapfelmeier et al. SCIENCE
- Ipilimumab: Unleashing the Power of the Immune System Through CTLA-4 Blockade
- (2010) Peter Boasberg et al. SEMINARS IN ONCOLOGY
- Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces
- (2009) Imke E Mulder et al. BMC BIOLOGY
- OR.100. PD-L1 Regulates the Development, Maintenance and Function of Induced-regulatory T Cells
- (2009) Loise Francisco et al. CLINICAL IMMUNOLOGY
- Interleukin-12 Receptor β2: From Cytokine Receptor to Gatekeeper Gene in Human B-Cell Malignancies
- (2009) Vito Pistoia et al. JOURNAL OF CLINICAL ONCOLOGY
- Composition and function of the human-associated microbiota
- (2009) Elisabeth M Bik NUTRITION REVIEWS
- Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine
- (2008) Ivaylo I. Ivanov et al. Cell Host & Microbe
- Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice
- (2008) P. D. Cani et al. DIABETES
- The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+cells
- (2008) Sokol Haxhinasto et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Mechanism of Anti-CTLA-4 Activity and the Negative Regulation of T-Cell Activation
- (2008) J. D. Wolchok et al. ONCOLOGIST
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started